MCL1 and central nervous system cancer: We found that over-expression of Mcl-1 cDNA partially rescued from killing by the combination treatment, suggesting that Mcl-1 is both sufficient and necessary for the combination treatment to exert its anti-glioma effects (Figure 5e).